- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Edgewise Therapeutics (NASDAQ:EWTX), Quotes and News Summary
Edgewise Therapeutics (NASDAQ: EWTX)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-08 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.280 | -0.300 | -0.0200 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Edgewise Therapeutics Questions & Answers
You can purchase shares of Edgewise Therapeutics (NASDAQ: EWTX) through any online brokerage.
Other companies in Edgewise Therapeutics’s space includes: GH Research (NASDAQ:GHRS), CinCor Pharma (NASDAQ:CINC), Aerie Pharmaceuticals (NASDAQ:AERI), DICE Therapeutics (NASDAQ:DICE) and Verona Pharma (NASDAQ:VRNA).
The latest price target for Edgewise Therapeutics (NASDAQ: EWTX) was reported by Goldman Sachs on Tuesday, May 24, 2022. The analyst firm set a price target for 5.00 expecting EWTX to fall to within 12 months (a possible -35.32% downside). 6 analyst firms have reported ratings in the last year.
The stock price for Edgewise Therapeutics (NASDAQ: EWTX) is $7.73 last updated June 29, 2022, 8:00 PM UTC.
There are no upcoming dividends for Edgewise Therapeutics.
Edgewise Therapeutics’s Q2 earnings are confirmed for Monday, August 8, 2022.
There is no upcoming split for Edgewise Therapeutics.
Edgewise Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.